NCT03374397View on ClinicalTrials.gov

PReservation Study of Ovarian Function And Hemostasis, and Its Safety of Surgiguard@ During Laparoscopic Ovarian Cystectomy

PHASE3CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

December 6, 2017

Primary Completion Date

August 31, 2019

Study Completion Date

August 31, 2019

Conditions
Ovarian Cyst Benign
Interventions
DRUG

Surgiguard

Hemostasis with Surgiguard during laparoscopic unilateral ovarian cystectomy

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT03374397 - PReservation Study of Ovarian Function And Hemostasis, and Its Safety of Surgiguard@ During Laparoscopic Ovarian Cystectomy | Biotech Hunter | Biotech Hunter